473 related articles for article (PubMed ID: 31287557)
21. Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes.
Anderson TM; Hess SD; Egilmez NK; Nwogu CE; Lenox JM; Bankert RB
J Cancer Res Clin Oncol; 2003 Oct; 129(10):565-8. PubMed ID: 12923636
[TBL] [Abstract][Full Text] [Related]
22. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
[TBL] [Abstract][Full Text] [Related]
23. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.
Bondarenko G; Ugolkov A; Rohan S; Kulesza P; Dubrovskyi O; Gursel D; Mathews J; O'Halloran TV; Wei JJ; Mazar AP
Neoplasia; 2015 Sep; 17(9):735-741. PubMed ID: 26476081
[TBL] [Abstract][Full Text] [Related]
24. Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer.
John T; Yanagawa N; Kohler D; Craddock KJ; Bandarchi-Chamkhaleh B; Pintilie M; Sykes J; To C; Li M; Panchal D; Chen W; Shepherd FA; Tsao MS
J Thorac Oncol; 2012 Jul; 7(7):1101-8. PubMed ID: 22617243
[TBL] [Abstract][Full Text] [Related]
25. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
[TBL] [Abstract][Full Text] [Related]
26. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
Okada S; Vaeteewoottacharn K; Kariya R
Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
[TBL] [Abstract][Full Text] [Related]
27. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
[TBL] [Abstract][Full Text] [Related]
28. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
[TBL] [Abstract][Full Text] [Related]
29. A novel immunodeficient rat model supports human lung cancer xenografts.
He D; Zhang J; Wu W; Yi N; He W; Lu P; Li B; Yang N; Wang D; Xue Z; Zhang P; Fan G; Zhu X
FASEB J; 2019 Jan; 33(1):140-150. PubMed ID: 29944447
[TBL] [Abstract][Full Text] [Related]
30. Cancer "Avatars": Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer.
Lynch IT; Abdelrahman AM; Alva-Ruiz R; Fogliati A; Graham RP; Smoot R; Truty MJ
J Am Coll Surg; 2023 Sep; 237(3):483-500. PubMed ID: 37326316
[TBL] [Abstract][Full Text] [Related]
31. Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts).
Hernández Guerrero T; Baños N; Del Puerto Nevado L; Mahillo-Fernandez I; Doger De-Speville B; Calvo E; Wick M; García-Foncillas J; Moreno V
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001663
[No Abstract] [Full Text] [Related]
32. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
33. A Method for the Establishment of Human Lung Adenocarcinoma Patient-Derived Xenografts in Mice.
Lundy J; Jenkins BJ; Saad MI
Methods Mol Biol; 2021; 2279():165-173. PubMed ID: 33683693
[TBL] [Abstract][Full Text] [Related]
34. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K
J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311
[TBL] [Abstract][Full Text] [Related]
35. Patient-derived tumor xenograft models established from samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.
Nakajima T; Geddie W; Anayama T; Ko HM; da Cunha Santos G; Boerner S; Wang T; Wang YH; Li M; Pham NA; Tsao MS; Yasufuku K
Lung Cancer; 2015 Aug; 89(2):110-4. PubMed ID: 26095073
[TBL] [Abstract][Full Text] [Related]
36. Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment.
Hernandez MC; Yang L; Leiting JL; Sugihara T; Bergquist JR; Ivanics T; Graham R; Truty MJ
Transl Oncol; 2019 Jan; 12(1):69-75. PubMed ID: 30273859
[TBL] [Abstract][Full Text] [Related]
37. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
[TBL] [Abstract][Full Text] [Related]
38. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW
Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650
[TBL] [Abstract][Full Text] [Related]
39. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
Kanaya N; Somlo G; Wu J; Frankel P; Kai M; Liu X; Wu SV; Nguyen D; Chan N; Hsieh MY; Kirschenbaum M; Kruper L; Vito C; Badie B; Yim JH; Yuan Y; Hurria A; Peiguo C; Mortimer J; Chen S
J Steroid Biochem Mol Biol; 2017 Jun; 170():65-74. PubMed ID: 27154416
[TBL] [Abstract][Full Text] [Related]
40. Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.
Corso S; Cargnelutti M; Durando S; Menegon S; Apicella M; Migliore C; Capeloa T; Ughetto S; Isella C; Medico E; Bertotti A; Sassi F; Sarotto I; Casorzo L; Pisacane A; Mangioni M; Sottile A; Degiuli M; Fumagalli U; Sgroi G; Molfino S; De Manzoni G; Rosati R; De Simone M; Marrelli D; Saragoni L; Rausei S; Pallabazzer G; Roviello F; Cassoni P; Sapino A; Bass A; Giordano S
Neoplasia; 2018 May; 20(5):443-455. PubMed ID: 29574251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
